X
More than 60,000 patients use Brite
4.6 stars
Your health finally understandable with Brite
Enter email and you're done. No subscription, no credit card.
Search, tap and you're done. Over 3,400 medicines.
Check, remind, get an overview.
Sarah K., 34
I finally understand my therapy. The app reminds me, answers my questions — and I don't feel alone with it anymore.
At a glance
Log your inhalers and symptoms in brite, get reminded of every dose and arrive at your appointment with a clear overview. Free of charge.
Never stop inhaled COPD medicines on your own — not even during symptom-free spells. Without the daily maintenance therapy, the risk of dangerous acute worsening (exacerbations) rises.
The abbreviation COPD stands for chronic obstructive pulmonary disease. Behind it lies a lasting inflammation of the airways that leaves the bronchi narrowed, so that exhaled air can only be pushed out with difficulty. "Obstructive" means exactly that: a narrowing that hinders airflow — above all when breathing out.
COPD is more than "just a cough". It involves two processes that often occur together: chronic bronchitis (permanently inflamed, mucus-clogged airways with cough and sputum) and pulmonary emphysema (an over-inflation in which the tiny air sacs lose their walls and the surface for gas exchange shrinks). Both explain the typical combination of cough, sputum and breathlessness.
You can picture a healthy lung as an elastic sponge with countless small chambers. In COPD the passages to these chambers are chronically inflamed and narrowed, while at the same time chamber walls are lost as the disease advances. Air still flows in when you breathe in, but it gets trapped when you breathe out — the lung becomes over-inflated and there is less room for fresh air. This is exactly the feeling many people describe: that they "can't get out again" what they breathed in.
Important to know: COPD is so far not curable, and the damage to the lung no longer fully reverses. But — and this is the crucial message — you can markedly slow its progression, ease the symptoms and considerably improve quality of life. The single most effective step is stopping smoking. Added to this are inhaled medicines, physical activity and good handling of acute flare-ups.
Internationally, COPD is classified using the so-called GOLD system (Global Initiative for Chronic Obstructive Lung Disease). It describes the disease from two angles: how severely lung function is impaired and — more important still for choosing treatment — how much the symptoms burden everyday life and how often acute worsening occurs.
The first angle is the severity of the airway narrowing, measured by a value called FEV1 (the volume of air you can forcefully breathe out in the first second). It is divided into four stages:
| GOLD stage | FEV1 (% of predicted value) | Meaning |
|---|---|---|
| GOLD 1 | 80 % and above | Mild impairment |
| GOLD 2 | 50–79 % | Moderate impairment |
| GOLD 3 | 30–49 % | Severe impairment |
| GOLD 4 | below 30 % | Very severe impairment |
The second angle is today the decisive one for treatment: the ABE groups. They are based not only on the lung value but on how you feel and how many exacerbations (acute worsenings) you had in the past year. This is why two people with the same FEV1 value are treated differently if one has hardly any symptoms and the other is constantly out of breath. In plain terms this means:
| Group | Who belongs to it? | What does it mean? |
|---|---|---|
| Group A | Few symptoms, at most one mild worsening per year without hospital | Usually a single airway-widening inhaler is enough |
| Group B | More noticeable everyday symptoms (breathlessness, reduced stamina), but still rare flare-ups | As a rule, a combination of two airway-widening agents |
| Group E | Frequent or severe exacerbations (two or more per year, or at least one requiring a hospital stay) — regardless of symptom severity | Combination therapy, often supplemented by an inhaled corticosteroid (ICS) if additional criteria are met |
The "E" stands for exacerbation and, in the current classification, has replaced the former groups C and D. The reason: frequent flare-ups are the most important warning sign of an unfavourable course and call for the most consistent treatment — regardless of how burdensome the disease feels in everyday life. Your group can change over time: anyone who has fewer flare-ups after stopping smoking and with good therapy can move from E back into a calmer group.
In COPD the symptoms develop gradually over years — and that is exactly what makes them so treacherous. Many people get used to the morning cough or put their increasing breathlessness down to getting older or a lack of fitness. This is why COPD is often only recognised late. The three classic leading complaints can be remembered by the shorthand "AHA" (in German): shortness of breath, cough, sputum.
As the disease progresses, further signs can be added: unintended weight loss and muscle wasting, frequent respiratory infections that last longer than usual, and a bluish discolouration of the lips and fingernails as a sign of oxygen deficiency. COPD also affects more than the lungs: the heart, muscles and metabolism are involved too, and many people additionally suffer from accompanying conditions such as heart failure, osteoporosis or depressive moods.
By far the most important trigger is smoking: in industrialised countries, around nine out of ten cases of COPD are due to inhaled tobacco smoke. Cigarette smoke permanently irritates the airways, sustains a chronic inflammation and, over time, destroys the fine lung tissue. Passive smoking and the smoking of water pipes or e-cigarettes are not harmless either.
But not every case of COPD is a "smoker's disease" — non-smokers can develop it too. Other risk factors are:
Why do some smokers develop COPD and others do not? Individual predisposition plays a role here — the sensitivity of the airways to pollutants varies from person to person. What is clear, though: the longer and more intense the exposure, the higher the risk. And for everyone alike, avoiding the triggering pollutants is the most effective protection.
The most important test for diagnosis is spirometry, a simple lung function test: you breathe in as deeply as possible through a mouthpiece and then breathe out as forcefully and completely as you can. Among other things, the FEV1 value (the volume in the first second) is measured in relation to the total amount of air breathed out. Crucial for a COPD diagnosis is that this narrowing persists even after a dose of an airway-widening spray — so it is not fully reversible. This is exactly what distinguishes COPD from asthma.¹
Depending on the situation, further examinations are added: a more detailed lung function test (body plethysmography), measurement of oxygen saturation, blood tests, an X-ray or CT image of the chest, and, where suspected, determination of alpha-1 antitrypsin in the blood. Questionnaires on symptom severity are also part of this, because the ABE classification is based precisely on everyday symptoms.
A frequent topic in the surgery is the distinction between COPD and asthma. Both lead to breathlessness and wheezing, but they are fundamentally different diseases with different treatment. This table shows the typical differences — in individual cases there are also mixed forms:
| Feature | COPD | Asthma |
|---|---|---|
| Typical age at onset | Usually from 40–50 years | Often already in childhood/adolescence |
| Main cause | Smoking, pollutants | Allergies, predisposition |
| Course of the breathlessness | Persistent, slowly increasing | In attacks, variable |
| Symptoms at night/in the morning | Morning cough with sputum | Nocturnal attacks, tightness in bouts |
| Reversibility in the test | Only partial, not complete | Usually well reversible |
| Response to corticosteroid spray | Only in a proportion of those affected | As a rule good |
The distinction matters because in asthma the inhaled corticosteroid forms the basis of treatment, whereas in COPD the airway-widening agents are at the forefront and corticosteroids are used only in a targeted way. In unclear cases or mixed pictures, specialist assessment in pulmonology is helpful.
Before it comes to sprays, one building block ranks first in COPD, more effective than any medicine: stopping smoking. It is the only measure proven to slow the accelerated loss of lung function. No inhaler, however well it works, can replace this step. And it is worthwhile at every stage — even someone who has smoked for decades and already has advanced COPD benefits from quitting.¹
Because stopping smoking is hard, there is effective support: behavioural therapy and counselling, nicotine replacement (patches, gum) and supporting medicines. The combination of guidance and replacement products significantly raises the chance of success — setbacks are part of the process and no reason to give up.
In very severe COPD with persistent oxygen deficiency in the blood, a long-term oxygen therapy may additionally become necessary, in which oxygen is supplied via a nasal cannula for many hours a day. In selected cases, surgical procedures or a lung transplant may be an option — special situations that are clarified in pulmonology.
The heart of the medicinal COPD treatment is inhaled agents that act directly in the airways. The great advantage of inhaling: the active substance reaches exactly where it is needed, and the burden on the rest of the body stays low. Two aims are distinguished above all — keeping the airways permanently open (bronchodilators) and dampening the inflammation (corticosteroids). Here are the drug classes in plain terms:¹,²
Which combination is the right one depends on your ABE group: group A often starts with a single bronchodilator, group B with the LABA+LAMA combination, and in group E the combination is supplemented by an ICS where needed. What matters is that the maintenance medicines are taken consistently, even during symptom-free spells — only then do they provide their preventive protection. The short-acting reliever spray remains additionally for acute situations.
brite reminds you of every dose and documents your symptoms without gaps — ready for your next appointment with the doctor.
Just as important as the right active substance is the correct use of the inhaler. Studies repeatedly show that a large proportion of those affected use their device incorrectly — with the result that the active substance ends up in the mouth or throat instead of in the bronchi. There are three basic device types that differ markedly in how they are handled:
| Device type | How it works | Common technique errors |
|---|---|---|
| Metered-dose inhaler (propellant spray) | One puff releases a fixed amount of active substance; slow inhalation needed | Actuating and inhaling not coordinated; inhaled too quickly; spray not shaken |
| Dry powder inhaler | You draw the powder out of the device yourself by inhaling forcefully and deeply | Inhaling too weakly; breathing out into the device (powder gets damp); device loaded incorrectly |
| Nebuliser | A device turns the liquid into a fine mist that you inhale calmly over several minutes | Incorrect cleaning; unsuitable mask/mouthpiece; breathing too hastily |
The decisive difference: with the metered-dose inhaler you have to inhale slowly and in a coordinated way, whereas with the dry powder inhaler you inhale forcefully and deeply to draw in the powder. Anyone who confuses the two loses a large part of the effect. With metered-dose inhalers a spacer (an inhalation aid, a kind of holding chamber) helps, because it makes the timing more relaxed and delivers more active substance into the lung.
You can find a detailed step-by-step guide for the various device types in the article Inhaling correctly. It is worth having the technique shown to you once at your leisure — it is one of the most effective and, at the same time, simplest ways to get more out of the therapy.
Set up reminders in brite for your maintenance and reliever spray and record how often you reach for the reliever spray — an important signal for the doctor's appointment.
An exacerbation is an acute worsening of COPD that goes beyond the usual day-to-day fluctuations — often triggered by a respiratory infection. It is dangerous because it can permanently worsen lung function and is a main reason for hospital stays. That is why it is so important to recognise the warning signs early and to have an agreed emergency plan.
Typical signs of an exacerbation are:
For such situations it makes sense to agree a written action plan in advance together with your surgery: when may you step up the reliever spray, when do you need a corticosteroid tablet or an antibiotic (if prescribed to you for emergencies), and from what point must you seek medical attention immediately? Anyone who has this plan to hand loses no valuable time in an emergency.
COPD is not treated over weeks but over years — often with several inhalers and a fixed daily rhythm. The therapy only works if it runs reliably and you notice worsening early. This is exactly where brite supports you.
